Chun-Hao Huang Selected Research

Nuclear Receptor Co-Repressor 1

6/2022	Correction to: Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines.
1/2022	Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun-Hao Huang Research Topics

Disease

25	Neoplasms (Cancer) 02/2022 - 07/2011
3	Liver Neoplasms (Liver Cancer) 01/2019 - 07/2014
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 07/2014
3	Inflammation (Inflammations) 06/2015 - 12/2011
2	Glioma (Gliomas) 06/2022 - 01/2022
2	Leukemia 10/2020 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2017
2	Carcinogenesis 01/2019 - 07/2014
2	Synovial Sarcoma (Synovioma) 12/2018 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 01/2017
2	Infections 12/2011 - 07/2011
1	Breast Neoplasms (Breast Cancer) 04/2021
1	Hypothyroidism 04/2021
1	Neoplasm Metastasis (Metastasis) 07/2020
1	Fatigue 01/2019
1	Carcinoma (Carcinomatosis) 01/2016
1	Adenocarcinoma 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2015
1	Thrombosis (Thrombus) 08/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015
1	Cholangiocarcinoma 07/2014
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2014
1	Stomach Neoplasms (Stomach Cancer) 12/2011
1	Cataract (Cataracts) 01/2011
1	Eye Diseases (Eye Disease) 01/2011
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2005
1	Diabetes Insipidus 01/2005
1	Autoimmune Hypophysitis 01/2005
1	Hypernatremia 01/2005
1	Hyponatremia 01/2005
1	Polyuria 01/2005

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2015
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
4	Small Interfering RNA (siRNA)IBA 01/2022 - 08/2014
4	Biomarkers (Surrogate Marker)IBA 01/2016 - 02/2014
3	Oncogene Proteins (Oncogene Protein)IBA 12/2018 - 01/2016
2	Temozolomide (Temodar)FDA LinkGeneric 06/2022 - 01/2022
2	Nuclear Receptor Co-Repressor 1IBA 06/2022 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 10/2020 - 07/2014
2	Lysine (L-Lysine)FDA Link 10/2020 - 01/2018
2	Androgen Antagonists (Antiandrogens)IBA 01/2020 - 01/2017
2	ChromatinIBA 01/2018 - 01/2017
2	EnzymesIBA 01/2018 - 12/2011
2	NestinIBA 06/2016 - 07/2014
2	AntioxidantsIBA 08/2015 - 12/2011
1	Doxycycline (Periostat)FDA LinkGeneric 01/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2021
1	Antineoplastic Agents (Antineoplastics)IBA 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020
1	venetoclaxIBA 10/2020
1	matrigelIBA 07/2020
1	Hormones (Hormone)IBA 01/2020
1	CytokinesIBA 12/2019
1	Interleukin-6 (Interleukin 6)IBA 12/2019
1	Mevalonic Acid (Mevalonate)IBA 01/2019
1	Polycomb Repressive Complex 1IBA 12/2018
1	Histone DemethylasesIBA 12/2018
1	Ribosomal DNA (rDNA)IBA 10/2018
1	Acrolein (Aqualin)IBA 10/2018
1	Ribosomal RNAIBA 10/2018
1	CaspasesIBA 10/2018
1	CyclinsIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	enzalutamideIBA 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Chelating AgentsIBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2017
1	DeuteriumIBA 01/2016
1	IsotopesIBA 01/2016
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2016
1	HydrogenIBA 01/2016
1	Microtubule ProteinsIBA 06/2015
1	Virulence Factors (Pathogenicity Factors)IBA 12/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2011
1	AntibodiesIBA 07/2011
1	Crystallins (Crystallin)IBA 01/2011
1	Vasopressins (Vasopressin)IBA 01/2005
1	Arginine Vasopressin (Argipressin)IBA 01/2005
1	GlucocorticoidsIBA 01/2005

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2005
4	Drug Therapy (Chemotherapy) 02/2022 - 12/2019
2	Intravenous Injections 01/2017 - 01/2016
1	Radiotherapy 02/2022
1	Lab-On-A-Chip Devices 07/2020
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2019
1	Intravenous Administration 01/2016
1	Lenses 01/2011